166 related articles for article (PubMed ID: 17402276)
1. Antihyperglycemic effects of newly synthesized 6,7-bis[2-(substitutedphenyl)-4-oxothiazolidin3yl1 quinoxaline 2,3-(1 FH, 4 H)-diones.
Pawar PY; Bhise SB
Indian J Physiol Pharmacol; 2006; 50(4):431-4. PubMed ID: 17402276
[No Abstract] [Full Text] [Related]
2. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
Vu CB; Bemis JE; Disch JS; Ng PY; Nunes JJ; Milne JC; Carney DP; Lynch AV; Smith JJ; Lavu S; Lambert PD; Gagne DJ; Jirousek MR; Schenk S; Olefsky JM; Perni RB
J Med Chem; 2009 Mar; 52(5):1275-83. PubMed ID: 19199480
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives.
Imran M; Yar MS; Khan SA
Acta Pol Pharm; 2009; 66(1):51-6. PubMed ID: 19226969
[TBL] [Abstract][Full Text] [Related]
4. Novel euglycemic and hypolipidemic agents. 1.
Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
[TBL] [Abstract][Full Text] [Related]
5. Substituted thiazolidinediones and thio-imidazolidinones: synthesis, structural study and pharmacological activity.
Albuquerque JF; Albuquerque A; Azevedo CC; Thomasson F; Galdino LS; Chantegrel J; Catanho MT; Pitta IR; Luu-Duc C
Pharmazie; 1995 Jun; 50(6):387-9. PubMed ID: 7651975
[TBL] [Abstract][Full Text] [Related]
6. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D
J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208
[TBL] [Abstract][Full Text] [Related]
7. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
[TBL] [Abstract][Full Text] [Related]
8. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines.
Dwivedi AP; Kumar S; Varshney V; Singh AB; Srivastava AK; Sahu DP
Bioorg Med Chem Lett; 2008 Apr; 18(7):2301-5. PubMed ID: 18353644
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antihyperglycemic evaluation of various protoberberine derivatives.
Bian X; He L; Yang G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1380-3. PubMed ID: 16359864
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines.
Satyanarayana M; Tiwari P; Tripathi BK; Srivastava AK; Pratap R
Bioorg Med Chem; 2004 Mar; 12(5):883-9. PubMed ID: 14980600
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.
Dang Q; Liu Y; Cashion DK; Kasibhatla SR; Jiang T; Taplin F; Jacintho JD; Li H; Sun Z; Fan Y; DaRe J; Tian F; Li W; Gibson T; Lemus R; van Poelje PD; Potter SC; Erion MD
J Med Chem; 2011 Jan; 54(1):153-65. PubMed ID: 21126019
[TBL] [Abstract][Full Text] [Related]
13. Chalcone based aryloxypropanolamines as potential antihyperglycemic agents.
Shukla P; Singh AB; Srivastava AK; Pratap R
Bioorg Med Chem Lett; 2007 Feb; 17(3):799-802. PubMed ID: 17095211
[TBL] [Abstract][Full Text] [Related]
14. Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents.
Aicher TD; Balkan B; Bell PA; Brand LJ; Cheon SH; Deems RO; Fell JB; Fillers WS; Fraser JD; Gao J; Knorr DC; Kahle GG; Leone CL; Nadelson J; Simpson R; Smith HC
J Med Chem; 1998 Nov; 41(23):4556-66. PubMed ID: 9804695
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
Crane L; Anastassiadou M; El Hage S; Stigliani JL; Baziard-Mouysset G; Payard M; Leger JM; Bizot-Espiard JG; Ktorza A; Caignard DH; Renard P
Bioorg Med Chem; 2006 Nov; 14(22):7419-33. PubMed ID: 16889967
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic and antihyperglycemic effect of Begonia malabarica Lam. in normal and streptozotocin induced diabetic rats.
Pandikumar P; Babu NP; Ignacimuthu S
J Ethnopharmacol; 2009 Jul; 124(1):111-5. PubMed ID: 19443148
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of quinoxaline-5,8-diones that inhibit vascular smooth muscle cell proliferation.
Chung HJ; Jung OJ; Chae MJ; Hong SY; Chung KH; Lee SK; Ryu CK
Bioorg Med Chem Lett; 2005 Jul; 15(14):3380-4. PubMed ID: 15950466
[TBL] [Abstract][Full Text] [Related]
18. 2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity.
Bhattarai BR; Shrestha S; Ham SW; Kim KR; Cheon HG; Lee KH; Cho H
Bioorg Med Chem Lett; 2007 Oct; 17(19):5357-60. PubMed ID: 17728130
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and hypoglycemic activity of some new theophylline derivatives.
Alafeefy AM; Alqasoumi SI; Abdel Hamid SG; El-Tahir KE; Mohamed M; Zain ME; Awaad AS
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):443-8. PubMed ID: 23701264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
